Ticker
ABCLCompany Name
ABCELLERA BIOLOGICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 1.4B | $ 117.44M | $ 1.2B | $ 88.07M |
3/31/2025 | $ 1.34B | $ 184.27M | $ 1.07B | $ 89M |
12/31/2024 | $ 1.36B | $ 181.32M | $ 1.09B | $ 89.92M |
9/30/2024 | $ 1.39B | $ 151.64M | $ 1.14B | $ 100.38M |
6/30/2024 | $ 1.41B | $ 173.31M | $ 1.11B | $ 133.47M |
3/31/2024 | $ 1.46B | $ 148.57M | $ 1.15B | $ 166.54M |
12/31/2023 | $ 1.49B | $ 158.32M | $ 1.16B | $ 168.23M |
9/30/2023 | $ 1.51B | $ 197.42M | $ 1.14B | $ 171.88M |
6/30/2023 | $ 1.54B | $ 204.75M | $ 1.16B | $ 174.55M |
3/31/2023 | $ 1.5B | $ 218.02M | $ 1.1B | $ 176.65M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ABCELLERA BIOLOGICS INC is calculated as follows: Assets [ $ 23.49M ] - Intangibles [ $ 0 ] - CashnEq [ $ 7.55M ]
(=) Core Assets [ $ 15.94M ]
Minimum
Dec 31, 2019
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.36B |
average | $ 798.38M |
median | $ 287.61M |
std | $ 1.05B |